Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Construction and validation of the My Medicines and Me Questionnaire for assessment of the self-reported side effects of psychotropic medication

Ashoorian, Deena M.a; Davidson, Rowan M.a,d; Rock, Daniel J.T.b,c,d; Dragovic, Milanb,d; Clifford, Rhonda M.a

International Clinical Psychopharmacology: July 2015 - Volume 30 - Issue 4 - p 224–229
doi: 10.1097/YIC.0000000000000072

We aimed to construct and assess the psychometric properties of the My Medicines and Me Questionnaire (M3Q), a self-report side-effect questionnaire for mental health patients. Thirty individuals taking a psychotropic medication completed the M3Q side-effect checklist along with the Liverpool University Neuroleptic Side Effect Rating Scale. Thirty healthy comparison individuals also completed the M3Q checklist. Data were analyzed using factorial analysis. Psychometric evaluations including validity and reliability testing were carried out on the questionnaire’s checklist. The original 54-item checklist of the M3Q was shortened to include only those items found to be significant in the factorial analysis. The revised 32-item checklist of the M3Q was found to be valid and reliable. The M3Q is a simple, valid and reliable questionnaire that can be used routinely in clinical practice for detecting bothersome side effects of a range of psychotropic medications. This will provide a platform for improved communication between the clinician and the patient.

aPharmacy Division, School of Medicine and Pharmacology

bSchool of Psychiatry and Clinical Neurosciences

cSchool of Population Health, The University of Western Australia, Crawley

dNorth Metropolitan Health Service Mental Health, Perth, Western Australia, Australia

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website (

Correspondence to Deena M. Ashoorian, B. Pharm, Pharmacy Division, School of Medicine and Pharmacology, The University of Western Australia, M315, 35 Stirling Highway, Crawley, WA 6009, Australia Tel: +61 08 6488 7516; fax: +61 08 6488 7532; e-mail:

Received November 4, 2014

Accepted February 24, 2015

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.